Patient Information

CYMBALTA (Duloxetine)

 

General Guidelines:

Cymbalta is one of the few drugs to treat neuropathic pain that is unlikely to lead to overweight

Adequate trial at a given dose might take 4-6 weeks

Pain relief usually occurs before antidepressants effects, i.e., less than one week

 

Minimize side effects:

  • Start at lower dose, e.g., 30 mg / day Cymbalta and then increase the dose slowly. Cymbalta has been used up to 120 mg / day to treat chronic pain.
  • Take with food
  • Take at bedtime
  • Nausea is the most common side effect and is likely to disappear in 7-10 days
  • Consider combining treatment with Cymbalta with another class of drug used to treat neuropathic pain (e.g. Lyrica)

 

 

Dosage Schedule

Maximum Total Daily

Dose

60 mg QD (Click here for details) 60 mg

 

 

Side effects of CYMBALTA:

  • Nausea
  • Dry mouth
  • Constipation
  • Loss of appetite
  • Tiredness
  • Drowsiness
  • Dizziness
  • Increased sweating
  • Blurred vision
  • Yawning

 

Patient exclusion criteria:

  • Epileptic Seizure
  • Closed Angle Glaucoma
  • High Blood Pressure
  • Blood Pressure Drop Upon Standing
  • Hardening of the Liver caused by Alcohol
  • Chronic Inflammation of the Liver
  • Hardening of the Liver
  • Liver Problems
  • Serious Kidney Problems
  • Manic-Depression,
  • Having Thoughts of Suicide
  • Habit of Drinking Too Much Alcohol

 

 

 

- Back to Patient Information - Back to Top 

 


Medication


The topics presented on this site are for informational purposes only. Any decision you make regarding your health care options should be made after consulting a qualified physician provider.

1.  CLONIDINE
2.  LYRICA
3.  METHADONE
4.  CYMBALTA
5.  CELEBREX


The RSD / CRPS Treatment Center and Research Institute is a licensed Ambulatory Surgical Center that is approved by the Florida Board of Medicine for Level II surgery.

The facility is regulated pursuant to the rules of the Board of Medicine as set forth in Rule Chapter 64B8, F.A.C.



 

Recent Articles

How to Determine the Effectiveness of Treatments for RSD / CRPS
Dr. Anthony F. Kirkpatrick, Chairman, Scientific Advisory Committee.



Ketamine Coma Procedure
Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study.



Medical Synopsis Prepared for Ketamine Coma Procedure
Research subjects discuss the risks and benefits of the ketamine coma procedure. This information is presented for patients who may be contemplating the procedure.


The International Research Foundation for RSD / CRPS is a 501(c)(3) (not-for-profit) organization in the United States of America.